Author

M. Lahnalampi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Organism:human· 3 Assay:scRNA-seq· 3 Approach:statistical model· 3 Research Focus:gene regulatory network inference· 2 Approach:machine learning (classical)· 2 Assay:ATAC-seq· 1

Frequent Co-Authors

A. Malyukova· 2 shared J. Mehtonen· 2 shared M. Heinaniemi· 2 shared O. Lohi· 2 shared O. Sangfelt· 2 shared S. Teppo· 2 shared A. D. Lamb· 1 shared A. Erickson· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Malyukova

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 27, 2023

Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia

A. Malyukova, M. Lahnalampi, T. Falques-Costa…·O. Sangfelt

DOI 10.1101/2023.03.27.534308

𝕏 PostBluesky

Cancer BiologybioRxivFeb 9, 2021

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer

S. Taavitsainen, N. Engedal, S. Cao…·A. Urbanucci

The paper uses single-cell ATAC and RNA sequencing to identify pre-existing and treatment-persistent stem-like cell subpopulations in prostate cancer models that predict treatment response.

DOI 10.1038/s41467-021-25624-1

humanscATAC-seq

𝕏 PostBluesky

Cancer BiologyGenome MedicinePeer-reviewedNov 20, 2020

Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1 positive pediatric leukemia identifies drug-targetable transcription factor activities

J. Mehtonen, S. Teppo, M. Lahnalampi…·M. Heinaniemi

This study uses scRNA-seq to analyze B-lymphoid differentiation and leukemic cell states in ETV6-RUNX1-positive pediatric leukemia, identifying drug-targetable transcription factor activities.

DOI 10.1186/s13073-020-00799-2

𝕏 PostBluesky